Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 6/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.63 |
| ▸ | CDC25B | P30305 | 1/20 | 0.63 |
| ▸ | PKLR | P30613 | 1/20 | 0.62 |
| ▸ | APAF1 | O14727 | 2/20 | 0.59 |
| ▸ | TDP2 | O95551 | 2/20 | 0.59 |
| ▸ | MAOA | P21397 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7979992 | 0.95 | BCL2 (0.91) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL8821657 | 0.86 | BCL2 (0.74) | BCL2MCL1MEN1KMT2APKLR | |
| SCHEMBL395884 | 0.84 | MCL1 (0.72) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL27428387 | 0.84 | BCL2 (0.72) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL11359105 | 0.84 | BCL2 (0.72) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL6051235 | 0.84 | BCL2 (0.72) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL7980260 | 0.83 | BCL2 (0.70) | BCL2MCL1MEN1KMT2APKLR | |
| Anthraquinone SCHEMBL28260408 | 0.83 | MEN1 (0.92) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL11072946 | 0.81 | BCL2 (0.67) | BCL2MCL1MEN1KMT2ACDC25B | |
| SCHEMBL6629644 | 0.81 | BCL2 (0.67) | BCL2MCL1MEN1KMT2ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-116598606-A | Application of aromatic micromolecular electrolyte additive | 中山大学 | 2023-08-15 | — | — | CN | claimed |
| US-9340643-B2 | Alizarin-based polymer colorants | XEROX CORPORATION (US) | 2016-05-17 | — | — | US | claimed |
| US-20160017090-A1 | Alizarin-Based Polymer Colorants | XEROX CORPORATION | 2016-01-21 | — | — | US | claimed |
| US-9181389-B2 | Alizarin-based polymer colorants | XEROX CORPORATION (US) | 2015-11-10 | — | — | US | claimed |
| EP-2859068-A1 | METHODS FOR SUPPRESSING DEHYDROGENATION | Elevance Renewable Sciences, Inc. (US) | 2015-04-15 | — | — | EP | claimed |
| US-20140342280-A1 | Alizarin-Based Polymer Colorants | XEROX CORPORATION (US) | 2014-11-20 | — | — | US | claimed |
| WO-2013188200-A1 | METHODS FOR SUPPRESSING DEHYDROGENATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| WO-2013188201-A1 | METHODS OF REFINING NATURAL OILS, AND METHODS OF PRODUCING FUEL COMPOSITIONS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| US-20130331586-A1 | METHODS OF REFINING NATURAL OILS, AND METHODS OF PRODUCING FUEL COMPOSITIONS | ELEVANCE RENEWABLE SCIENCES, INC. | 2013-12-12 | — | — | US | claimed |
| US-20130331630-A1 | METHODS FOR SUPPRESSING DEHYDROGENATION | ELEVANCE RENEWABLE SCIENCES, INC. | 2013-12-12 | — | — | US | claimed |
| EP-4700821-A1 | TREATMENT SOLUTION AND METHOD FOR TREATING OBJECT TO BE TREATED | FUJIFILM Corporation (JP) | 2026-02-25 | — | — | EP | disclosed |
| US-20260028558-A1 | TREATMENT LIQUID AND METHOD FOR TREATING OBJECT TO BE TREATED | FUJIFILM CORP (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-1988004694-A1 | DIGITAL THRESHOLD COLOR CONTROL SYSTEM | ENZYMATICS, INC. (US) | 1988-06-30 | — | — | WO | disclosed |
| EP-0147639-B1 | STABILIZED SOLUTIONS OF HYDROXYL AMINE OR SALTS THEREOF | BASF Aktiengesellschaft (DE) | 1987-07-22 | — | — | EP | disclosed |
| US-4576804-A | HYDROXYANTHRAQUINONES | BASF AKTIENGESELLSCHAFT (DE) | 1986-03-18 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4299946-A | THERMOSETTING RESINS | RHONE-POULENC INDUSTRIES (FR) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028558-A1 | TREATMENT LIQUID AND METHOD FOR TREATING OBJECT TO BE TREATED | AOC1, EPCAM, AOC2 | BCL2 376/4885MCL1 459/4885MEN1 4569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.